The vast majority of interactions that have been documented with alprazolam are with medications that modulate CYP3A4 activity. Compounds that happen to be inhibitors or inducers of CYP3A could be predicted to enhance or reduce plasma alprazolam concentrations, respectively. Drug products which were examined in vivo, together with their impact on g